FREE Shippingto US, AU, UK and EU on all orders over $149
/ / /

Ergoferon 20s lozenges

$15.80

1eea32717a18

Description

The instruction for medical use of homeopathic medicine (Leaf insert) Ergoferon the Trade name Ergoferon Mezhdunarodnoye the unlicensed name Is not present the Dosage form, the Tablet dosage for resorption Pharmacotherapeutic group Anti-infectious drugs of system use. Antiviral means for system use. Antiviral means of direct action. Antiviral drugs other. ATX J05AX code. Indications Prevention and treatment as a part of complex therapy of the acute respiratory viral infections caused by a virus of influenza, a parainfluenza, adenovirus, respiratory syncytial virus, a coronavirus in adults and children are more senior than 6 months. The list of the data necessary prior to use of the Contraindication – the increased individual sensitivity to drug components, – children is younger than 6 months. – hereditary intolerance of a galactose, deficiency of lactase of falls or glyukozo-galaktozny malabsorption. Necessary precautionary measures at use It is inapplicable. Interaction with other medicines of Cases of incompatibility with other medicines is not registered so far. Special preventions Special instructions monohydrate in this connection patients are not recommended to appoint it with a congenital galactosemia, a sprue of glucose or with a congenital lactose intolerance is a part of drug lactoses. Use in pediatrics the Drug Ergoferon is used at children 6 months in the same mode of dosing, as at adults are more senior. During pregnancy or a lactation Safety of use of Ergoferon at pregnancy and in the period of a lactation was not studied. Use of the drug Ergoferon at emergency is recommended, after advantage ratio assessment for mother and potential risk for a fruit or the child. The feature of influence of drug on ability to run the vehicle or potentially dangerous Ergoferon mechanisms does not influence ability to run vehicles and other potentially dangerous mechanisms. Recommendations about use the dosing Mode the Drug Ergoferon is used at children 6 months in the same mode of dosing, as at adults are more senior. Inside. On one reception – 1 tablet (approximately in 15 minutes prior to meal or in 15 minutes after meal). The tablet should be held in a mouth, without swallowing, before full dissolution. When prescribing drug children of younger age (from 6 months to 6 years) are recommended to dissolve a tablet in a small amount (1 tablespoon) of boiled water of room temperature. As a part of complex therapy of a SARS. Treatment needs to be begun at emergence of the first symptoms of an acute infection. In the 1st day of treatment take 8 pill according to the following scheme: on 1 tablet each 30 minutes in the first 2 hours (only 5 tablets in 2 hours), then during the same day accept on 1 tablet 3 times at regular intervals. Since 2 days and further accept on 1 tablet 3 times a day to an absolute recovery. Prevention of a SARS. On 1-2 tablets a day. The recommended duration of a preventive course is defined individually and can be 1 – 6 months. If necessary drug can be combined with other antiviral and symptomatic means. Measures which need to be accepted in case of overdose At overdose are possible the dispepsichesky phenomena (nausea, vomiting, diarrhea) caused by the excipients which are a part of drug. Treatment consists in drug withdrawal and purpose of symptomatic therapy, for example, of oral rehydration (plentiful drink). The measures necessary at the admission of one or several doses of medicine in case of the admission of reception of a dose of drug the passed dose need to be accepted as soon as possible and to continue a course of administration of drug on the begun scheme. It is impossible to double a dose instead of the forgotten dose. Recommendations about the request for consultation to the health worker for explanation of a route of administration of medicine Before use of drug consult with the doctor. The description of undesirable reactions which are shown at standard use of LP and measure which should be accepted in this case. For classification of undesirable reactions by the frequency of emergence the following conditions were used: very often (≥1/10), it is frequent (≥1/100, & lt, 1/10), sometimes (≥1/1000, & lt, 1/100), is rare (≥1/10000, & lt, 1/1000, is very rare (& lt, 1/10000), it is not known (frequency cannot be calculated on the basis of the available data). Within clinical trials, post-registration independent researches and monitoring of spontaneous messages, cases of development of the undesirable reactions having a certain communication with administration of drug are not registered. Reactions of the increased individual sensitivity to drug components are possible. Frequency of emergence of undesirable reactions cannot be calculated on the basis of post-marketing observation. If at administration of drug there are undesirable reactions, it is necessary to stop reception and to see a doctor. At emergence of the expected medicinal reactions to address the health worker, the pharmaceutical worker or directly in the information database on undesirable reactions (actions) to medicines, including messages about inefficiency of medicines the Representative office of LLC NPF MATERIA MEDIKA HOLDING in RK Almaty, Seyfullin St. 498. Ph./fax: 2734713. E-mail: kz@dep.materiamedica.ru Additional data Composition of medicine One tablet contains active agents – antibodies to scale to interferon of the person affinely the cleaned 0.006 g *, antibodies to a histamine affinely the cleaned 0.006 g *, antibodies to CD4 affinely cleaned 0.006 g*. * are applied on lactoses monohydrate in the form of mix of three active aqueous-alcoholic cultivations of the substance divorced respectively in 10012, 10030, 10050 times. excipients: lactoses monohydrate, cellulose microcrystalline, magnesium stearate. The description of outward, a smell, taste of the Tablet of a ploskotsilindrichesky form, with risky and a facet, from white till almost white color. On the flat party from risky the inscription MATERIA MEDICA is put, on other flat party the inscription ERGOFERON is put. A form of release and packing of the Tablet for resorption. On 20 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil. On 1, 2 or 5 blister strip packagings together with the instruction for medical use in the Kazakh and Russian languages place in a pack from cardboard. Period of storage 3 years. Not to apply after an expiration date! Storage conditions In the place protected from light, at a temperature not above 25 °C. To store out of children’s reach! Prescription status Without prescription. Data on LLC NPF MATERIA MEDIKA HOLDING producer, Russia, 127473, Moscow, 3rd Samotechny Lane, 9. Ph./fax: +7 (495) 684-43-33. Holder of the registration certificate of LLC NPF MATERIA MEDIKA HOLDING, Russia. Russia, 127473, Moscow, 3rd Samotechny Lane, 9. Ph./fax: +7 (495) 684-43-33. The name, the address and a contact information (phone, the fax, e-mail) of the organization in the territory of the Republic of Kazakhstan, the accepting claim (offer) on quality of medicines from consumers and responsible for post-registration observation of safety of medicine Representative office of LLC NPF MATERIA MEDIKA HOLDING in RK Almaty, Seyfullin St. 498. Ph./fax: 2734713. E-mail: kz@dep.materiamedica.ru

Reviews

There are no reviews yet.

Be the first to review “Ergoferon 20s lozenges”

Your email address will not be published.